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Generation of Intracellular Signals by Low 
Density Lipoprotein Is Independent of the 
Classical LDL Receptor 
Agapios Sachinidis, Rudolf Locher, and Wilhelm Vetter 
Low dens i ty l ipopro te in cholesterol (LDL) a n d apo­
l ipopro te in B-100 (1 to 15 / jg /mL) h a d no significant 
influence on t h e inos i to l - l ,4 ,5- t r i sphosphate (InsPa) 
format ion in vascular smooth musc le cells a n d fi­
broblas t s . Low dens i ty l ipopro te in cholesterol (15 
/ /g /mL) i n d u c e d an e leva t ion of in t race l lu la r C a 2 + 
from 85 to approx ima te ly 210 n m o l / L in vascular 
smooth musc le cells from rat aor ta i n t h e absence 
or in t h e p resence of 15 / / g / m L monoc lona l an t i ­
bod ies agains t t h e classical low dens i ty l ipopro te in 
receptor or in t h e p resence of apo l ipopro te in B-100. 
Moreover , in b o t h h u m a n cu l tu red fibroblasts from 
normocholes te ro lemic i n d i v i d u a l s a n d from pa­
t ien ts w i t h famil ia l hypercho les t e ro lemia h o m o z y ­
gote class 1, LDL induced a dose -dependen t r ise of 
free in t race l lu la r calcium a n d a b iphas ic change of 
in t race l lu la r pH . Since homozygo te class 1 fibro­
b las ts are classical L D L receptor nega t ive , a n d as 
an t ibod ies agains t th i s receptor, as we l l as apo l ipo­
p ro te in B-100, d id not a t t enua te t h e L D L - i n d u c e d 
e leva t ion of cytosolic calcium, w e conclude tha t 
L D L m i g h t modify vascular act ivi ty via t h e o b ­
served in t race l lu la r changes w i t h o u t i nvo lv ing the 
classical l ow dens i ty l ipopro te in receptor . A m J Hy ­
pe r t ens 1991;4:274-279 
KEY WORDS: LOW dens i ty l ipoprote in , vascular 
musc le cells, fibroblasts, in t race l lu la r Ca 2 + a n d pH, 
phospha t idy l inos i to l t u rnove r . 
R ecently, a correlation between blood pressure and serum cholesterol levels has been de­scribed, suggesting that those patients with higher blood pressure values tend to have 
higher cholesterol levels. 1 Low density lipoprotein, the 
major cholesterol-carrying lipoprotein of h u m a n 
plasma, delivers cholesterol to cells by binding to the 
classical LDL receptors. The cholesterol is then internal­
ized by endocytosis. These receptors recognize the apo-
From the Medical Policlinic, Universtät Bonn, Germany (AS), and 
Department of Internal Medicine, University Hospital, Zürich, Swit­
zerland (RL, WV). 
This work was supported by a fellowship from the Jung-Stiftung for 
science and research, Hamburg, Germany. 
This study is based on data presented at the American Society of 
Hypertension annual meeting, May 10 to 12, 1989. 
Address correspondence and reprint requests to Prof. W. Vetter, 
MD, Department of Internal Medicine, University Hospital Rämis-
trasse 100, CH-8091, Zürich, Switzerland. 
lipoprotein B-100 hydrophobic polypept ide. 2 Low den­
sity lipoprotein is considered to be the main atherogenic 
class of lipoproteins, and contains 60 to 70% of the total 
serum cholesterol. Epidemiological and pharmacologi­
cal studies indicate that the lowering of LDL-cholesterol 
is accompanied by a decrease in the risk of hyperten­
s i o n . 3 4 These results suggest that increased LDL-cho­
lesterol levels might modify vascular reactivity in hu­
mans with hypercholesterolemia. In addition, vascular 
smooth muscle cells (VSMC) play a key role in the path­
ophysiology of both hypertension and atherosclero­
sis . 5 ' 6 In order to elucidate cellular mechanisms by 
which LDL could be involved in the development of 
hypertension, we demonstrated very recently in cul­
tured VSMC that LDL can induce an elevation of intra­
cellular free C a 2 + ([Ca 2 +]i) and a biphasic change of in­
tracellular p H (pHj) via the N a + / H + exchanger. In 
addition, LDL induced vasoconstriction of rat thoracic 
aortic rings.7 
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In the present report, we examined whether these 
intracellular changes could be mediated by the classical 
LDL receptor via stimulation of the phosphatidylinosi-
tol (Ptlns) turnover, and thus leading to a release of 
cytosolic calcium. For this purpose, we investigated the 
effect of LDL in VSMC in the presence of monoclonal 
LDL receptor antibodies ( IgGC 7 ) 8 and apolipoprotein 
B-100 on the Ptlns turnover as well as on [Ca 2+]i and 
pHj . Moreover, we studied the effect of LDL on [ C a 2 ^ 
and pHi in LDL receptor negative cultured fibroblasts 
from patients with familial hypercholesterolemia (FH) 
homozygote class 1 mutat ions. Genes from these muta­
tions cannot produce any LDL receptor protein. 2 
MATERIALS A N D M E T H O D S 
Mater ia l s Fura 2/pentaacetoxymethyl ester (fura 2 / 
AM) and [2 / ,7 /-bis(carboxyethyl)-5,6-carboxyfluore-
scein]-pentaacetoxymethyl ester (BCECF/AM) were 
obtained from Calbiochem (Zürich, Switzerland). Dul­
becco's modified Eagles medium (DMEM), Ham ' s F-10 
and Dulbecco's phosphate-buffered saline (PBS) were 
obtained from Amimed (Zürich, Switzerland). Ethy-
lenglycol-bis-(2-aminoethyl) tetraacetic acid (EGTA), 
4-(2-hydroxyethyl)piperazine-l-ethane-sulfonic acid 
(HEPES) Tris(hydroxymethyl)aminomethane (Tris-
base), and other chemicals were obtained from Sigma 
Chemical (Zürich, Switzerland). Monoclonal low den­
sity lipoprotein antibodies as well as myo-[2- 3H]inositol, 
and s tandard [ 3 H]-Inositolpolyphosphates were ob­
tained from Amersham International, Amersham, 
Buckinghamshire, England. Normal and Class 1 FH ho-
mocygote fibroblasts were obtained from The H u m a n 
Genetic Mutant Cell Repository Institute for Medical 
Research, USA. 
LDL Isolat ion Low density lipoprotein (density, 1.019 
to 1.063 g /mL) was isolated from the plasma of 5 indi­
vidual normocholesterolemic subjects (serum choles­
terol < 6.2 mmol /L) by ultracentrifugation according to 
Redgrave et al . 9 The LDL fraction was dialyzed against 
0.15 m o l / L N a C l / 1 m m o l / L EDTA, p H 7.4, and used 
within 3 weeks. Oxidation of LDL was prevented by 
adding 5 / /mol /L butylated hydroxytoluene (BHT) 
throughout . The LDL was stored at 4 ° C and used within 
3 weeks; no changes in activity were observed during 
this period of time. Determination of protein was per­
formed by Lowry's m e t h o d . 1 0 
Cul tu r e of Vascular Smooth Muscle Cells Vascular 
smooth muscle cells were isolated from rat aorta (fe­
male, Wistar-Kyoto strain, 6 to 8 weeks old) and recul-
tured several times in accordance with the method of 
Ross. 1 1 The cells were allowed to grow for 4 to 5 days in 
5% C 0 2 , 9 5 % air at 37°C. The culture medium was 
Dulbecco's modified Eagle's (DMEM) medium supple­
mented with 10% fetal calf serum. 
C u l t u r e of F ibroblas ts Normal and FH homozygote 
fibroblasts were obtained from the H u m a n Genetic Mu­
tant Cell Repository Institute for Medical Research and 
recultured several times after de tachment of the con­
fluent cells with Puck's Saline A physiological solution 
containing 0.04% t ryps in /0 .02% EDTA buffer. The 
cells were allowed to grow as described for the 
VSMC. 
M e a s u r e m e n t of Inos i to lphospha tes Cells were 
seeded in Petri dishes (60 m m diameter) and grew in the 
presence of myo-[2- 3H]inositol (4 / /Ci /mL) for 3 days. 
During this time the cells reached confluence. They 
were washed three times with HEPES buffer, followed 
by a 2 h incubation in DMEM without FCS. After 2 
other washes with buffer, cells were incubated for 20 
min in DMEM containing 20 m m o l / L LiCl in order to 
inhibit inositol-1 monophospha tase activity. Then cells 
were stimulated with LDL for various periods of time. 
The reactions were terminated by the addit ion of icecold 
8% trichloroacetic acid (TCA). Samples were kept on ice 
for 30 min before removing TCA by extracting the sam­
ples with diethyl e ther . 1 2 Radiolabeled inositol phos ­
phates were analyzed and quantified by standardized 
anion exchange H P L C . 1 3 The 1.25 mL fractions were 
transferred to scintillation vials and radioactivity was 
determined in the liquid scintillation counter. Peak 
identification of inosi tol-1-monophosphate, inositol-
1,4-bisphosphate, and inositol-1,4,5-trisphosphate, 
were performed by using s tandard radiolabeled [ 3H]in-
ositol phosphates . Cells were incubated with 1, 7, and 
15 / / g / m L LDL for different time periods. Positive con­
trol experiments were performed by stimulation of the 
cells with 100 n m o l / L endothelin for different t ime 
periods. 
M e a s u r e m e n t of Free In t race l lu la r C a 2 + [Ca 2+]j Con­
fluent cells were detached with 0.04% t ryps in /0 .02% 
EGT A / P u c k ' s Saline A physiological solution after 5 to 
10 min at 37° C. Then cells were incubated with 2 / / m o l / 
L fura-2 pentaacetoxymethyl ester at 37°C for 20 min in 
HEPES-buffer (20 m m o l / L HEPES, 16 m m o l / L glu­
cose, 130 m m o l / L NaCl, l m m o l / L M g S 0 4 - 7 H 2 0 , 0.5 
m m o l / L C a C l 2 , Tris-base, pH , 7.4) supplemented with 
1% bovine serum albumin (BSA). After loading, cells 
were washed and suspended in HEPES buffer (approxi­
mately 2 X 10 6 cells/mL). The Ca 2 + - fu ra -2 fluorescence 
was measured at 37°C while stirring in a SLM-Aminco 
SPF-500 (Urbana, IL), spectrofluorometer (excitation 
wavelengths: 340 and 380 nm; emission: 505 nm). Fluo­
rescence was corrected for cellular autofluorescence. 
Fluorescence signals were calibrated using 0 .5% Triton 
X-100 for measurement of maximum fluorescence fol­
lowed by the addition of 2 m m o l / L M n C l 2 for min imum 
fluorescence according to Grynkiewicz et a l . 1 4 
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M e a s u r e m e n t of pHj These measurements were per­
formed using the method of Berk et a l 1 5 with the fluores­
cence p H indicator BCECF. Cells were loaded as de­
scribed for the fura-2 loading method in HEPES buffer 
with 2 / /mol /L BCECF-pentaacetoxymethyl ester for 20 
min at 37°C. For the fluorescence measurements the 
following wavelengths were set: excitation wave­
lengths: 492 and 438 nm; emission wavelength 525 nm. 
The calibration curve was performed by permeabilizing 
the cells with 30 / /mol /L digitonin as previously de­
scribed. 
RESULTS 
LDL or Apo l ipopro te in B-100 Has N o Effects on Ino-
s i to lphospha te Format ion In order to investigate 
whether LDL can stimulate the phosphatidyinositol 
(Ptlns) turnover, the formation of radiolabeled inositol-
1 monophospha te (InsPx), inositol-1,4-bisphosphate 
(InsP 2) and inositol- l ,4,5-tr isphosphate (InsP 3 ) in 
VSMC was determined by using standardized anion 
HPLC. Table 1 shows the t ime-dependency of the myo-
[ 3H]inositol labeled InsP j , I n s P 2 , and In sP 3 formation in 
VSMC resulting from endothelin and LDL stimulation. 
N o significant synthesis of InsP j , I n s P 2 , and In sP 3 could 
be observed after stimulation periods of 20 sec, 1, 3, 5, 
10, and 20 min with 15 / / g / m L LDL or apolipoprotein 
B-100 compared to the unst imulated cells. Similar re­
sults were obtained with 3 and 7 / / g / m L LDL or apoli­
poprotein B-100. Endothelin induced a strong t ime-de­
pendent formation of the inositol polyphosphate with a 
maximum at approximately 10 min. In comparison with 
unst imulated cells or cells in the presence of 15 / / g / m L 
LDL or apolipoprotein B-100, endothelin caused an ap­
proximately 6-, 13-, and 4-fold higher formation of 
InsP j , I n s P 2 , and InsP 3 in VSMC, respectively. 
Apo l ipopro te in B-100 or Monoc lona l An t ibod ies 
Agains t t h e LDL Receptor (IgGC 7 ) C a n n o t Influence 
t h e LDL I nduced Elevat ion of [Ca 2 + ] i Apolipoprotein 
B-100 (3,7,15 / /g /mL) had no effects on [ C a 2 ^ . Prein­
cubation of VSMC for 30 min with 15 / / g / m L apolipo­
protein B-100 had no effect on the LDL induced release 
of [ C a 2 + ] i . The maximal LDL induced elevation of 
[Ca 2 +]i , occuring at 20 sec, was 212 ± 19 in the absence 
and 208 ± 2 1 n m o l / L in the presence of 15 / / g / m L apo­
lipoprotein B-100 (mean ± SD, η = 4, basal value 70 ± 
9 n m o l / L η = 8). Addition of various concentrations of 
IgGC 7 to VSMC for 30 min failed to influence [ C a 2 ^ . 
Preincubation of VSMC for 30 min with 1,7,35, and 70 
/ / g / m L I g G C 7 at 37°C, followed by a 15 / / g / m L LDL 
stimulation did not abolish or reduce the LDL induced 
elevation of [Ca 2 +]i . 
LDL Elevates [Ca 2 + ] j in N o r m a l a n d Receptor Nega­
t ive Fibroblas ts Figure 1 shows the concentration-re­
sponse curve for the maximal LDL induced rise of [ C a 2 ^ 
at 15 sec in the presence of extracellular Ca 2 +. Low den­
sity lipoprotein concentrations ranging from 1 to 7 / / g / 
mL caused a dose-dependent increase of [ C a 2 - ^ . Low 
density lipoprotein concentrations higher than 7 / / g / m L 
caused no further significant rise of [Ca 2 +]i . Similar re­
sults were obtained in normal fibroblasts in both the 
presence and absence of extracellular C a 2 + . As demon­
strated in Figure 2a, 15 / / g / m L LDL induced, in the 
presence of extracellular C a 2 + , a rapid rise in [Ca 2 + ] i 
(basal value = 73 ± 8 n m o l / L , mean ± SD, η = 12) 
with a maximum at 15 sec. The rise of LDL induced 
stimulation of [ C a 2 ^ declined after 15 sec and reached 
the resting level within 1.0 min. Low density lipoprotein 
also stimulated a rapid rise in [Ca 2 + ] i in the Ca 2+-free 
buffer (Figure 2b). This rise, however , was less pro­
nounced than in the presence of extracellular C a 2 + . 
TABLE 1. EFFECT OF LDL AND ENDOTHELIN ON INOSITOLPOLYPHOSPHATES FORMATION 
IN VSMC (MEAN*) 
Stimulated with 100 nmol/L Stimulated with 15 //g/mL LDL 
Endothelin (counts/min) (counts/min) 
Time (min) I n s P ^ InsP 2 * InsP 3 § InsPjt InsP 2 * InsP 3 § 
0.0 421 142 62 432 129 66 
0.3 398 215 115 415 138 60 
1.0 626 725 158 423 142 68 
3.0 701 572 148 442 125 57 
6.0 1626 1219 179 415 132 62 
10 2507 1544 246 410 119 64 
15 2924 1446 218 390 131 58 
20 3031 788 138 423 125 62 
* Distribution of SD was less than 12°/o of the mean (n = 3). 
f Inositol 1-phosphate; J Inositol 1,4-bisphosphate; § Inositol 1,4,5-trisphosphate. 
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FIGURE 1. Concentration-dependent effect of 1, 3, 7, and 15 
ßg/mL LDL on [Ca2+]{. As [Ca2+]{ was maximal within 15 sec, 
[Ca2+]{ obtained at 15 sec stimulations were plotted and given as 
mean ± SD, η = 4. 
LDL C h a n g e s pHi in N o r m a l a n d Receptor Nega t ive 
Fibroblas ts Figure 3 illustrates the effect of LDL on pHj 
of receptor negative fibroblasts in HEPES buffer. Addi­
tion of 7 / / g / m l LDL exerted in both cell types a biphasic 
effect on pH{ (basal value = 7.04 ± 0.03, η = 10). Ini­
tially, within 2 min a rapid acidification o f 0 . 0 6 ± 0 . 0 2 
(n = 5) p H units occured, followed by a subsequent 
prolonged alkalinization of 0.12 ± 0.04 p H units. Simi­
lar results were obtained with normal fibroblasts. 
D I S C U S S I O N 
Recently, low concentrations of LDL (1 to 30 / /g /mL) 
induced elevation of [Ca2+]i in VSMC were reported. 7 
This elevation was partly due to mobilization of calcium 
from intracellular stores. In addition, LDL caused p H t 
shifts in VSMC, probably via activation of N a + / H + ex­
change. Furthermore, a mitogenic effect of LDL was also 
demons t r a t ed . 1 6 ' 1 7 It is recognized that such intracellular 
changes are mainly triggered by vasoactive agonists, eg, 
All or endothelin, or by the receptor-dependent Pt lns 
turnover signal sys tem. 1 8 These Ptlns turnover-acti­
vated intracellular changes are putative signals for cell 
constriction and cell proliferation and consequently 
may play an important role in the development of hy­
per tens ion. 1 9 Since LDL showed similar intracellular 
changes, we examined whether the classical LDL recep­
tor is involved in the elevation of [Ca 2 - 1 ^ and pHj . Sur­
prisingly, our results indicate that these LDL induced 
intracellular changes are independent of the classical 
LDL receptor and do not occur via stimulation of the 
Ptlns turnover signal system. These findings are sup­
ported by the following observations. 
In contrast to endothelin, which caused u p to a 5-fold 
4 0 6 0 8 0 
Time (sec) 
1 2 0 
FIGURE 2. Effect of 15 ßg/mL LDL on [Ca2+]i in cultured 
human fibroblasts in the presence and absence of extracellular 
Ca2+. LDL (15 ßg/mL) was applied to fura-2-loaded LDL receptor 
negative fibroblasts in HEPES buffer, containing 1 mmol/L CaCl2 
(a) and in Ca2+-free HEPES-buffer, containing 1 mmol/L EGTA 
(b). Changes in fluorescence were monitored for 3 min. After sub­
traction of autofluorescence, changes in 340/380 nm excitation 
wavelength ratio by the emission wavelength of 505 nm were 
converted into corresponding levels of [Ca2+]i. 
and 25-fold increase of I n sP 3 and In sP 2 formation, re­
spectively, LDL was not able to stimulate the formation 
of the Pt lns- turnover metabolites InsP^, I n s P 2 , and 
I n s P 3 . Our results are thus in contrast wi th recent re­
p o r t s 2 0 ' 2 1 showing that low concentrations of LDL in­
duced an net increase of I n s P ^ I n s P 2 , and In sP 3 in 
VSMC within 10 min. Compared with the strong effects 
of classical vasoactive agonists on inositol phospha te 
formation, these increases appear to be of less impor­
tance for triggering cellular responses. The differences 
4 
T i m e 
τ 1 Γ 
6 8 10 
( m i n ) 
12 
ι 
14 
FIGURE 3. Effect of LDL on pH{ in cultured human fibroblasts. 
LDL (15 ßg/mL) was applied to BCECP-loaded LDL receptor nega­
tive and normal human fibroblasts. Changes in fluorescence were 
monitored for 20 min in HEPES-buffer. After calibration of the 
fluorescence signal by permeabilizing the cells with 30 ßmol/L 
digitonin, changes in 492/438 nm excitation wavelength ratio by 
the emission wavelength 525 nm were converted into correspond­
ing levels of pH{. 
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in the results of our s tudy with those of others may 
reflect VSMC differences, depending on the isolation 
procedure, strain and age of the animal, cultivation con­
ditions, and number of passages. The much higher sensi­
tivity of the HPLC method in separating inositol phos­
p h a t e s , 1 3 compared to the customary m e t h o d 1 2 using 
Dowex columns, would be another possible explanation 
for differing reports on the effect of LDL on Pt lns turn­
over. 
Preincubation of the VSMC cultures with monoclonal 
antibodies ( IgGC 7 ) 8 against specific surface LDL recep­
tor could not abolish or at tenuate the intracellular ef­
fects of LDL. 
Apolipoprotein B-100, a constituent of LDL, is a hy­
drophobic polypeptide with a molecular mass of 513 
kDa. It facilitates the endocytosis of LDL after binding 
on the classical LDL receptor. 2 As shown in our experi­
ments , apolipoprotein B-100 cannot stimulate the for­
mation of inositol polyphosphates . Additionally, prein­
cubation of the VSMC cultures with apolipoprotein 
B-100 could not affect the LDL induced elevation of 
[Ca**],. 
Similar LDL-induced changes of [Ca 2+] â and pH 4 in 
normal and receptor negative fibroblasts were ob­
served, indicating that the observed LDL induced intra­
cellular changes are independent of the specific LDL 
receptor. The lack of LDL to activate Pt lns turnover in 
both cell types is consistent with the former findings. 
Since LDL induced an approximately 2-fold increase 
of the 4 5 C a 2 + influx compared with that in unst imulated 
cel ls , 1 7 it can be assumed that LDL has some relation to 
C a 2 + channels. Opening of nonspecific cation channels, 
which induce depolarization of the membrane and thus 
trigger the activity of Ca 2 + channels , leads to an eleva­
tion of [Ca 2 - 1 -]!. Low density lipoprotein induced mobili­
zation of Ca 2 + from intracellular stores may be brought 
about by an u p to n o w u n k n o w n mediator. One exam­
ple of such a mediator is GTP, which in pancreatic cells 
mobilizes C a 2 + from intracellular s tores . 2 2 According to 
another repor t , 2 3 indicating that an influx of extracellu­
lar Ca 2 + mobilized the release of Ca 2 + from the sarco­
plasmic reticulum in VSMC, the possibility exists that 
the LDL induced release of C a 2 + from intracellular stores 
may be triggered by a similar mechanism. Our results do 
not exclude the existence of another LDL receptor in 
VSMC or fibroblasts. A nonclassical LDL receptor, the 
"seavenger receptor" has been described in m o n o c y t e / 
macrophages and endothelial cells. This receptor recog­
nizes and takes u p modified LDL at a rate many times 
higher than native LDL. 2 4 
From our findings two principal questions arise: Is the 
isolated LDL native or modified? Although isolation of 
LDL was performed in the presence of the antioxidants 
BHT or ascorbic acid, a minimized oxidation of LDL 
cannot be excluded. Are there any artifactual LDL ad­
herent factors causing the observed intracellular 
changes? After LDL precipitation by 70% ethanol no 
activity in the 70% ethanol supernatant was found (un­
published observation) indicating that the observed 
intracellular changes were not induced by adherent 
factors with a small molecular mass. However, 
nondialyzable factors cannot be excluded and it is con­
ceivable that these putative factors have stimulatory ef­
fects only in association with the LDL particle. 
Although the real concentrations of LDL in the extra­
cellular fluid are unknown, experiments on the LDL 
clearance in several tissues indicate that LDL can occur 
in the extracellular space . 2 5 ' 2 6 The relatively low in vitro 
concentrations of LDL triggering the aforementioned 
cellular events probably correspond to in vivo concen­
trations of LDL in extra vascular fluids. These LDL con­
centrations are much lower than those in plasma due to 
the diffusion barrier offered by vascular endothelium. 
In addition, there are fluctuations in LDL concentrations 
due to d ie tary , 2 7 physiological, 2 8 and pharmacological 
manipula t ion . 2 9 In addition, binding and uptake of LDL 
have been observed following incubation of cultured rat 
VSMC with 10 / / g / m L of homologous LDL. 3 0 - 3 1 
In conclusion, our findings suggest that LDL, apart 
from its physiological function as a cholesterol transport 
molecule, can also contribute to the pathogenesis of car­
diovascular diseases by elevating [Ca 2 + ] i and pHj . Con­
sequently, in h u m a n s with hypercholesterolemia, LDL-
cholesterol might modify vascular reactivity without 
involving the specific LDL receptor. 
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